Profil
Kathy Dong is currently the President & Chief Executive Officer at Electra Therapeutics, Inc. and also serves as a Director at Neuron23, Inc. Previously, she worked as the Chief Operating Officer at Star Therapeutics, Inc. Dr. Dong holds an MBA and a doctorate from the University of New Mexico School of Medicine.
Aktiva positioner av Kathy Dong
| Företag | Position | Start |
|---|---|---|
Neuron23, Inc.
Neuron23, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that focuses on developing precision medicines for genetically defined neurological and immunological diseases | Direktör/Styrelseledamot | 2022-06-14 |
Electra Therapeutics, Inc.
Electra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapies for immunological diseases and cancer | Verkställande Direktör | 2023-12-11 |
Tidigare kända positioner av Kathy Dong
| Företag | Position | Slut |
|---|---|---|
Star Therapeutics, Inc.
Star Therapeutics, Inc. BiotechnologyHealth Technology Develops antibody therapies | Verksamhetschef | - |
Kathy Dongs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Kopplade företag
| Privata företag | 4 |
|---|---|
University of New Mexico School of Medicine
University of New Mexico School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neuron23, Inc.
Neuron23, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that focuses on developing precision medicines for genetically defined neurological and immunological diseases | Commercial Services |
Electra Therapeutics, Inc.
Electra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapies for immunological diseases and cancer | Health Technology |
Star Therapeutics, Inc.
Star Therapeutics, Inc. BiotechnologyHealth Technology Develops antibody therapies | Health Technology |
















